Mylan NV
www.mylan.com
Latest From Mylan NV
Another Botox Competitor: Revance Prepares Longer-Lasting RT002 For BLA Submission
A claim that RT002's duration of efficacy surpasses the leading neurotoxin – Allergan's blockbuster Botox – will be put to the test when Revance seeks US FDA approval to treat frown lines in the first half of this year. The company's Botox biosimilar with Mylan also could move forward in 2019.
Korea IND Filing Moves Alteogen's Eylea Biosimilar Forward
South Korean biotech Alteogen is progressing the development of its Eylea biosimilar both at home and abroad, with the hope of becoming a global first mover with its version in wet AMD, backed by formulation and manufacturing patents.
Analysts Upbeat On Aurobindo After Strong Earnings
Analysts are enthusiastic about the US earnings prospects of leading Indian generic firm Aurobindo after the company reported a nearly 20% jump in consolidated net profit for the third quarter, and declared it would focus on digesting its acquisitions.
Mylan Launches Advair Generic Wixela At 70% Discount To GSK's Branded Drug List Price
Two weeks after the product's approval, Mylan finally has launched Wixela and revealed a big price cut for the asthma and COPD medicine over the brand; the actual savings for patients remains dependent on payer negotiations and other factors.
Company Information
- Industry
-
Pharmaceuticals
-
Drug Delivery
- Transdermal
- Generic Drugs
-
Drug Delivery
- Therapeutic Areas
- Non-Specific
- Alias(es)
- Mylan Laboratories Inc.
- Mylan Inc.
- Ownership
- Public
- Headquarters
-
Worldwide
-
Europe
-
Western Europe
-
UK
-
UK
-
Western Europe
-
Europe
- Parent & Subsidiaries
-
Mylan NV
- Agila Specialties Pvt. Ltd.
- Alphapharm Pty. Ltd.
- Dow Hickam Pharmaceuticals
- Meda AB
- Merck Generics Group
- Mylan Bertek Pharmaceuticals Inc.
- Mylan Institutional
- Mylan Laboratories Ltd.
- Mylan Pharmaceuticals Inc.
- Mylan Pharmaceuticals Pvt. Ltd.
- Mylan Specialty LP
- Mylan Technologies Inc.
- Penederm Inc.
- Somerset Pharmaceuticals Inc.
- Senior Management
-
Heather Bresch, CEO
Ken D Parks, CFO
Anthony Mauro, Chief Commercial Officer - Contact Info
-
Mylan NV
Phone: 1707 853000
Bldg. 4, Trident Pl.
Mosquito Way
Hatfield, PA AL10 9UL
UK
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice